États-Unis · Agences & temps réel · Bloomberg

Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

Publié par Bloomberg · États-Unis il y a 2 h

Genmab A/S shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence…

Lire l'article complet sur Bloomberg Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.bloomberg.com)

Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

À lire aussi

Baby orangutans in India expose illegal wildlife trade as experts question a billionaire’s zoo

Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026

Dragonfly On-demand Webinar: Middle East: Anticipating a convergence of conflicts

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

Partager

À lire aussi

Baby orangutans in India expose illegal wildlife trade as experts question a billionaire’s zoo

Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026

Dragonfly On-demand Webinar: Middle East: Anticipating a convergence of conflicts

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows